U.K. drug maker GlaxoSmithKline has secured its takeover of longtime partner Human Genome Sciences after agreeing to pay more, a move to expand GSK’s drug portfolio in crucial areas: biologic drugs and treatments for the hundreds of millions of people ...
Tagged with: benlysta biotech diabetes glaxosmithkline human genome sciences lupus poison pill rockville takeover
Read More »